Breaking
President Trump Announces Potential U.S. Access to Venezuelan Oil Reserves
Former White House Teleprompter Operator Settles With CFTC Over Insider Trading on Prediction Market
Workplace Surveillance Expands Across US Amid Privacy Concerns
CBC/Radio-Canada to Label 9/11 Attacks as Terrorism After Criticism
Seneca Nation Demands Reversal of ‘Lake America’ Renaming Order, Citing Treaty and Indigenous Rights
Friday August 28, 2026
⛅
75°
Minneapolis, MN
Partly Cloudy
Minneapolis
▾
Atlanta
GA
Boston
MA
Charlotte
NC
Chicago
IL
Cleveland
OH
Dallas
TX
Denver
CO
Detroit
MI
Houston
TX
Indianapolis
IN
Los Angeles
CA
Miami
FL
Minneapolis
MN
✓
New York
NY
Orlando
FL
Philadelphia
PA
Phoenix
AZ
Portland
OR
Raleigh
NC
Sacramento
CA
San Francisco
CA
Seattle
WA
St. Louis
MO
Tampa
FL
Washington
DC
No signals found
View all signals
→
Become a Contributor
Local
Business
Politics
Press Releases
Reporter
SK Biopharmaceuticals. Co., Ltd.
1
Articles Published
4
Communities Covered
Published Articles
Press Release
SK Biopharmaceuticals to In-License Epilepsy Drug Candidate ‘Opakalim’
Aug 26